Phytotherapeutic medicines: reality or myth?

Rev Assoc Med Bras (1992)

Department of Endocrine Gynecology and Menopause, Discipline of Gynecology and Obstetrics, Hospital das Clínicas, Faculty of Medicine of the University of São Paulo; São Paulo, Brasil.

Published: March 2019

Download full-text PDF

Source
http://dx.doi.org/10.1590/1806-9282.65.3.292DOI Listing

Publication Analysis

Top Keywords

phytotherapeutic medicines
4
medicines reality
4
reality myth?
4
phytotherapeutic
1
reality
1
myth?
1

Similar Publications

Article Synopsis
  • The study focuses on a genus of plants known for their therapeutic properties, particularly for treating conditions like tuberculosis and urinary infections, with an emphasis on a species endemic to Brazil.
  • It identifies and analyzes the main compounds in its aqueous extract, finding Arbutin, Caffeic acid 4-O-glucoside, and Dihydroformononetin to be the most abundant; the gastrointestinal absorption and ability to cross the blood-brain barrier of these compounds were evaluated.
  • The research indicates that Arbutin and Dihydroformononetin may lead to drug synthesis and shows potential for phytotherapeutic use, although some mutagenicity predictions require cautious interpretation.
View Article and Find Full Text PDF

Critical analysis of Echinacea preparations marketed in Germany.

Naunyn Schmiedebergs Arch Pharmacol

November 2024

Institute of Pharmacology, Hannover Medical School, Carl-Neuberg-Str. 1, 30625, Hannover, Germany.

Article Synopsis
  • - Colds lead to significant work incapacity in 2023, impacting the German economy, with Echinacea products being popular as immune boosters and gaining attention during the COVID-19 pandemic.
  • - A study examined 22 Echinacea herbal preparations, highlighting inconsistencies in their ingredients and formulations, despite their similar market presentation.
  • - To better match clinical research with real-world products, new studies should analyze the actual compositions of these preparations and consider factors like dosage and work incapacity as outcomes.
View Article and Find Full Text PDF
Article Synopsis
  • Apigenin, a flavonoid thought to benefit cardiovascular health, was studied for its effects on vascular function in Spontaneously Hypertensive Rats (SHRs) to understand its mechanisms of action.
  • Vascular beds from SHRs were tested with varying doses of apigenin, showing that its ability to lower blood pressure depended on the presence of endothelial cells and was significantly reduced by inhibitors of nitric oxide and potassium channels.
  • The research concluded that apigenin causes vasodilation primarily through endothelial nitric oxide and calcium-activated potassium channels, suggesting its potential for therapeutic use in cardiovascular diseases and the need for more clinical studies.
View Article and Find Full Text PDF

Cardiometabolic syndrome (CMS) is a complex clinical condition that encompasses metabolic dysregulation, cardiovascular disease, and diabetes risk factors. Worldwide, CMS is underdiagnosed, and its occurrence significantly increases cardiovascular morbimortality. Despite available pharmacological treatments, the approach is fragmented, and the associated clinical conditions are treated independently.

View Article and Find Full Text PDF

Products from various parts of species are traditionally applied as a cardiotonic. In Europe and the USA, mainly Jacq. (Lindm.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!